A clinical trial in Japan for a drug to treat sufferers of acute strokes has hit a snag due to surging import costs, prompting doctors to run a crowdfunding campaign to maintain the trial.
Stroke doctors such as Manabu Inoue of the National Cerebral and Cardiovascular Center in Osaka Prefecture are currently trying to get domestic approval for tenecteplase, a clot-busting drug for brain infarction, more commonly known as a stroke.
